Phase II Study of Vinflunine in Malignant Pleural Mesothelioma

Armen Hareyan's picture

Vinflunine shows encouragin sings for treatment in Malignant Pleural Mesothelioma.


Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM.

Patients and Methods: Patients with a histologically confirmed diagnosis of

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.